Log In
Print
BCIQ
Print
Print this Print this
 

AV-203

  Manage Alerts
Collapse Summary General Information
Company Aveo Pharmaceuticals Inc.
DescriptionEpidermal growth factor receptor 3 (EGFR3; HER3; ErbB3) targeted antibody
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today